Fri, Aug 22, 2014, 6:39 AM EDT - U.S. Markets open in 2 hrs 51 mins


% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

  • viseslinger viseslinger Jan 10, 2013 8:53 AM Flag

    Motley Fool: Maintains a CAPScall of outperform on Incyte and fully expect the drugmaker to charge higher from here.

    When Incyte wasn't raving about Jakafi for MF -- which was few and far between -- it did note that its late-stage trial utilizing Jakafi for the treatment of polycythemia vera should deliver results in the latter half of this year with an expectation of a new drug application filing by the first-half of 2014 assuming all endpoints are met. It also has an ongoing mid-stage trial for Jakafi for the treatment of pancreatic cancer.

50.19-1.47(-2.85%)Aug 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.